This site is intended for US audiences only.

Skip to content

Main Navigation

For Patients
For Healthcare Professionals
Resources

Mary Bird Perkins Cancer Center

Posted on December 2, 2023 (April 5, 2024) by lum-dev

Baton Rouge, LA 70809

Post navigation

The George Washington University Cancer Center

Ficlatuzumab is an investigational drug and has not yet been approved by the US Food and Drug Administration (FDA).

Footer Navigation

Terms of Use
Privacy Policy
Cookie Policy
Contact Us

© 2024 AVEO Pharmaceuticals, Inc. All rights reserved. US-MAT-00305 4/24